Shionogi & Co., Ltd - Strategy, SWOT and Corporate Finance Report
Summary
Shionogi & Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Shionogi & Co., Ltd. (Shionogi or 'the group') produces and sells pharmaceutical products. It is involved in the research, development, manufacture, and marketing of ethical drugs, over-the-counter (OTC) drugs and diagnostic products. It caters to the healthcare needs and addresses the social issues of society. The company offers its products under the brands of AIMIX, IRTRA, Crestor, Irbetan, Cymbalta, Pirespa, Differin, Rapiacta, Finibax, OxyContin, OxiNorm, OxiFast, Sedes, Correct Series, opon Series, Brightpoc Flu. Shionogi has 51 subsidiaries and three affiliates. It operates in Japan, Europe, North America and other regions of the world. The company is headquartered in Osaka, Japan
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook